# Sciegen Pharmaceuticals Inc – FDA Inspection, May 15, 2026

Source: https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/a00d1c75-1c9e-4b7c-82cc-eda5065cbf25
Source feed: FDA_Inspections

> FDA inspection 1317246 of Sciegen Pharmaceuticals Inc, May 15, 2026. 2 citations under 21 CFR part 211. Form 483 issued. 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1317246
- Company Name: Sciegen Pharmaceuticals Inc
- Inspection Date: 2026-05-15
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New York District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1297968 - 2025-12-19](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/dbc62b1e-da3f-4e51-b99e-d9e5f6698380)
- [FDA Inspection 1229682 - 2024-02-20](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/c0bb89dd-507e-46db-a766-fad3d39acd40)
- [FDA Inspection 1204858 - 2023-04-21](https://www.keypedia.com/records/fda_inspections/sciegen-pharmaceuticals-inc/78debf30-0ef4-42cc-be44-6bb8ef0669d0)
- FDA Inspection 1178870 - 2022-09-02
- FDA Inspection 1159297 - 2021-12-20

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/daniel-l-zheng/5e3d993f-654e-4d40-a2c8-69c5e396499f)
- [Issuing Officer](https://www.keypedia.com/people/emmanuel-t-donyina/a8f23469-487e-490d-bf02-41b2a60bb396)

Company: https://www.keypedia.com/companies/sciegen-pharmaceuticals-inc/814ff2a4-e264-431f-bffa-9932abda619d

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d